Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand
1 other identifier
interventional
117
1 country
1
Brief Summary
The goal of this clinical trial is to Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis, to assess the prevalence of lice and associated risk factors between severity groups by using questionnaire-based surveys and diagnostic tests among school children in Baan Nayao, Chachoengsao Province, Thailand. The main questions it aims to answer are
- What is more effective between Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel in the treatment of Pediculosis capitis in school children in Baan Nayao, Chachoengsao Province, Thailand?
- What is Prevalence and risk factors of being infected with in head lice in school and community?
- What is Side effects of Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel? Participants will receive three different drugs are
- oral ivermectin
- 4% Dimeticone liquid gel
- 1% Permethrin shampoo Participants voluntarily received oral ivermectin as per medical prescription, with treatment outcomes, side effects, and satisfaction levels monitored following two treatment cycles. Those exhibiting persistent lice infestations were subsequently treated with 1% permethrin shampoo, the standard treatment, while alternatives were provided for individuals allergic to permethrin. These findings will contribute to formulating tailored, effective, and safe treatment regimens for future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Dec 2023
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2024
CompletedFirst Submitted
Initial submission to the registry
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
March 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedMarch 27, 2024
March 1, 2024
3 months
March 20, 2024
March 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison effectiveness of Oral ivermectin , 1% Permethrin shampoo and 4% Dimeticone liquid gel in the treatment of Pediculosis capitis
Treatment of Pediculosis capitis was considered effective by the absence of live lice
From enrollment to the end of treatment at 28 days
Secondary Outcomes (3)
Prevalence of head louse infestation among school children in Chachoengsao Province, Thailand
From enrollment to the end of screening at 28 days
Side effects of Oral ivermectin , 1% Permethrin shampoo and 4%Dimeticone liquid gel
From enrollment to the end of treatment at 28 days
The association factor of head lice infestation among school children in Chachoengsao Province, Thailand
From the enrollment to the end of treatment at 28 days
Study Arms (3)
Oral ivermectin
EXPERIMENTALFor the treatment of head lice infestation, participants are receiving two single doses of oral ivermectin on days 0 and 7 of the experiment. (spaced 7 days apart)
Dimeticone liquid gel
EXPERIMENTALFor the treatment of head lice infestation, participants are receiving one application of 4% dimenticone liquid gel on day 0 of the experiment.
Permethrin shampoo
NO INTERVENTIONParticipants are receiving two applications of 1% permethrin shampoo, which is the current drug of choice for Pediculosis capitis, on days 0 and 7. This group is defined as a control group.
Interventions
Oral formulation (3mg tablet) Dosage: 2 single doses of 200 mcg/kg given 7 days apart
topical formulation (liquid gel) only 1 application
Eligibility Criteria
You may qualify if:
- The participants are studying in Na Yao border patrol police school, Ban Na Isan border patrol police school or Phu Ngam wittaya school.
- Approved consent from the participants' caretaker
You may not qualify if:
- History of Allergic sensitization to these substances
- The participants with chronic scalp disorder
- Those who had used a pediculicide within the previous two weeks
- Those who had recently used bleaches, dyes, or permanent wave products
- Anyone taking trimethoprim or cotrimoxazole at evaluation or during the previous four weeks
- Those who had participated in another clinical trial within one month
- Pregnancy
- Body weight \< 20 kg.
- Loss to follow up in a second dose
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Phramongkutklao college of medicine
Bangkok, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2024
First Posted
March 27, 2024
Study Start
December 15, 2023
Primary Completion
March 18, 2024
Study Completion
May 1, 2024
Last Updated
March 27, 2024
Record last verified: 2024-03